Outcome of patients with advanced gastro-intestinal stromal tumours crossing over to a daily imatinib dose of 800mg after progression on 400mg
Author:
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference14 articles.
1. Current clinical management of gastrointestinal stromal tumors;Tosoni;Expert Rev Anticancer Ther,2004
2. Gastrointestinal stromal tumors respond to tyrosine kinase-targeted therapy;Maki;Curr Treat Options Gastroenterol,2004
3. Safety and efficacy of imatinib (STI571) in metastatic gastrointestinal stromal tumours: a phase I study;van Oosterom;Lancet,2001
4. Imatinib mesylate (STI-571 Glivec®, Gleevec™) is an active agent for gastrointestinal stromal tumours, but does not yield responses in other soft-tissue sarcomas that are unselected for a molecular target
5. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors;Demetri;N Engl J Med,2002
Cited by 327 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Molecular Advances in the Treatment of Advanced Gastrointestinal Stromal Tumor;The Oncologist;2023-06-14
2. Sunitinib versus imatinib dose escalation after failure of imatinib standard dose in patients with advanced Gastrointestinal stromal tumors – a real-world multi-center study;Translational Oncology;2023-04
3. Molecular Tailored Therapeutic Options for Advanced Gastrointestinal Stromal Tumors (GISTs): Current Practice and Future Perspectives;Cancers;2023-03-30
4. The Application of Virtual Therapeutic Drug Monitoring to Assess the Pharmacokinetics of Imatinib in a Chinese Cancer Population Group;Journal of Pharmaceutical Sciences;2023-02
5. 2023 GEIS Guidelines for gastrointestinal stromal tumors;Therapeutic Advances in Medical Oncology;2023-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3